Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc.verified

SBFM

Price:

$0.0801

Market Cap:

$7.97M

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand ...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2022-02-15

Stock Exchange

NASDAQ

Ticker

SBFM

The PE Ratio as of April 2024 (TTM) for Sunshine Biopharma, Inc. (SBFM) is -0.05

According to Sunshine Biopharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.05. This represents a change of -98.06% compared to the average of -2.57 of the last 4 quarters.

Sunshine Biopharma, Inc. (SBFM) Historical PE Ratio (quarterly & annually)

How has SBFM PE Ratio performed in the past?

The mean historical PE Ratio of Sunshine Biopharma, Inc. over the last ten years is -0.19. The current -0.05 PE Ratio has changed 2.60% with respect to the historical average. Over the past ten years (40 quarters), SBFM's PE Ratio was at its highest in in the December 2021 quarter at 0.06. The PE Ratio was at its lowest in in the June 2022 quarter at -11.20.

Quarterly (TTM)
Annual

Average

-0.19

Median

-0.00

Minimum

-1.47

Maximum

-0.00

Sunshine Biopharma, Inc. (SBFM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Sunshine Biopharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 607.40%

Maximum Annual PE Ratio = -0.00

Minimum Annual Increase = -99.66%

Minimum Annual PE Ratio = -1.47

Quarterly (TTM)
Annual
YearPE RatioChange
2023-1.47303.56%
2022-0.36607.40%
2021-0.00-99.66%
2020-0.02105.93%
2019-0.00-85.11%
2018-0.00-95.47%
2017-0.001.95%
2016-0.00-49.45%
2015-0.00-8.02%
2014-0.00-71.27%

Sunshine Biopharma, Inc. (SBFM) Average PE Ratio

How has SBFM PE Ratio performed in the past?

The current PE Ratio of Sunshine Biopharma, Inc. (SBFM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.61

5-year avg

-0.37

10-year avg

-0.19

Sunshine Biopharma, Inc. (SBFM) PE Ratio vs. Peers

How is SBFM’s PE Ratio compared to its peers?

Sunshine Biopharma, Inc.’s PE Ratio is less than Shionogi & Co., Ltd. (0), less than Alimera Sciences, Inc. (3.37), greater than China SXT Pharmaceuticals, Inc. (-8.16), greater than Guardion Health Sciences, Inc. (-0.83), less than Shuttle Pharmaceuticals Holdings, Inc. (4.67), greater than Lifecore Biomedical, Inc. (-1.23), greater than Mallinckrodt plc (-2.87), less than Journey Medical Corporation (-0.00), greater than Petros Pharmaceuticals, Inc. (-22.61), less than Sonoma Pharmaceuticals, Inc. (-0.01), greater than Alpha Teknova, Inc. (-0.38), greater than Phibro Animal Health Corporation (-2.67), less than SOHM, Inc. (35.84), greater than Silver Spike Investment Corp. (-9.70), less than Eagle Pharmaceuticals, Inc. (11.40), less than null (3.15),

Build a custom stock screener for Sunshine Biopharma, Inc. (SBFM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sunshine Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sunshine Biopharma, Inc. (SBFM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sunshine Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Sunshine Biopharma, Inc.'s PE Ratio?

How is the PE Ratio calculated for Sunshine Biopharma, Inc. (SBFM)?

What is the highest PE Ratio for Sunshine Biopharma, Inc. (SBFM)?

What is the 3-year average PE Ratio for Sunshine Biopharma, Inc. (SBFM)?

What is the 5-year average PE Ratio for Sunshine Biopharma, Inc. (SBFM)?

How does the current PE Ratio for Sunshine Biopharma, Inc. (SBFM) compare to its historical average?